🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06786871
Enrolling by invitation Observational

ARTLifeLine: Assisted Reproduction Technology (ART) Family Health and Development Trajectory Cohort (ARTLL)

NCT06786871 · tracked via the Priya Life Science China tracker
Sponsor
Peking University Third Hospital
Phase
Observational
Started
2025-01-20
Last updated
2025-01-22

Condition(s) studied

Reproductive Techniques, AssistedFamilyCohort StudiesDevelopment, InfantReproductive Issues

Investigational drug(s) / intervention(s)

IVF treatment

IVF treatment: Methods or procedures for the in vitro processing of human oocytes, sperm, or embryos for fertility purposes

Study summary

The goal of this observational study is to study the health status of infertile couples and their offspring using assisted reproductive technologies. The main questions it aims to answer are:

1. On the basis of the assisted reproduction birth cohort and related research established by the team in the early stage, further expand the construction of the "tracking cohort of familial health and development using assisted reproduction", combine emerging technologies such as cross-database linking and integration, multi-omics sequencing and classical cohort research design, and carry out long-term longitudinal follow-up across generations, covering the whole life cycle and health in multi-dimension.
2. Build a disease risk prediction model for pregnant women and children with assisted reproduction.
3. Delineate the growth curve and neurobehavioral development trajectory of assisted reproductive offspring at different stages.
4. Evaluate the adolescent fertility potential and risk factors of assisted reproductive offspring.

Eligibility

Sex
ALL
Min age
0 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: (1) Previous or planned IVF treatment; (2) paper or electronic medical records during fertility treatment are available; (3) Obtain informed consent from the research subject or guardian of the minor. Exclusion Criteria: (1) Other assisted reproductive treatment techniques that exclude in vitro fertilization, including guided intercourse, ovulation induction, artificial insemination, etc.; (2) refusal of enrollment; (3) withdraw or abort the study at any time and for any reason.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Peking University Third Hospital, Beijing, China Beijing Beijing Municipality
Peking University Third Hospital Beijing Beijing Municipality

More Peking University Third Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06786871 on ClinicalTrials.gov ↗ ← All trials in China